Related Experiment Video
Updated: May 8, 2026
15:09
The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
Published on: October 3, 2012
SUMO and Parkinson's disease.
1Department of Neurology, University Medical Center Goettingen, Waldweg 33, 37073, Goettingen, Germany, keckerm@gwdg.de.
Neuromolecular Medicine
|August 28, 2013
Summary
Small ubiquitin-related modifier (SUMO)ylation is linked to Parkinson's disease (PD) pathology. SUMOylation plays a crucial role in cellular processes and neurodegeneration, highlighting its importance in PD.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- Parkinson's disease (PD) is a common neurodegenerative disorder with motor and non-motor symptoms.
- Pathology involves Lewy bodies and fibrillar alpha-synuclein.
- SUMOylation, a posttranslational modification, is observed in PD cases.
Purpose of the Study:
- To explore the role of SUMOylation in Parkinson's disease.
- To understand the link between SUMOylation and neurodegeneration.
- To investigate SUMO's involvement in PD-related cellular processes.
Main Methods:
- Immunohistochemical analysis of SUMO in PD cases.
- Literature review on SUMOylation mechanisms and functions.
- Analysis of PD-associated genes and pathways.
Main Results:
- SUMO immunoreactivity is present in Parkinson's disease.
- Key disease-associated proteins are SUMO-modified.
- SUMOylation is implicated in regulating transcription, signaling, and stress response.
Conclusions:
- SUMOylation is linked to neurodegeneration in Parkinson's disease.
- SUMOylation is involved in cellular stress responses and mitochondrial dysfunction in PD.
- SUMOylation is a critical factor in PD pathogenesis and cellular homeostasis.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...